IVI Madrid   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Madrid Spain (1990)

Organization Overview

First Clinical Trial
2008
NCT00780858
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

IVI Madrid | IVIRMA MADRID